Research News

METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity

Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma stem cells) within the tumour, makes it difficult to eradicate glioblastoma as these cells can persist indefinitely and resist conventional therapies. In this paper, A/Prof Derrick Ong and his team discovered that a protein named methyltransferase 8 (METTL8) is involved in the 3-methylcytosine modification of specific mitochondrial-tRNAs, which indirectly promotes mitochondrial translation and respiration. Surprisingly, the METTL8-mediated mitochondrial respiration influences the hypoxia-regulatory cancer pathway, which helps maintain glioblastoma hallmarks. This finding has important translational value because it may explain why drugs targeting the hypoxia pathway fail to eradicate this cancer clinically. Targeting the METTL8 protein could be a new therapeutic strategy to eliminate glioblastoma.

Read more: https://www.nature.com/articles/s41419-024-06718-2

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →
Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …

Read More →
Research News

Understanding RNA Changes and Cancer Development

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …

Read More →